Drug Information

Drug General Information
Drug ID
D08EGA
Former ID
DNC014122
Drug Name
N-(cis-9-cis-12-octadecadienyl)sulfamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530389]
Structure
Download
2D MOL

3D MOL
Formula
C18H36N2O2S
Canonical SMILES
CCCCCC=CCC=CCCCCCCCCNS(=O)(=O)N
InChI
1S/C18H36N2O2S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-23(19,21)22/h6-7,9-10,20H,2-5,8,11-18H2,1H3,(H2,19,21,22)/b7-6-,10-9-
InChIKey
DGNCNCVVPPGGNM-HZJYTTRNSA-N
PubChem Compound ID
44614165
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Inhibitor [530389]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 530389Eur J Med Chem. 2009 Dec;44(12):4889-95. Epub 2009 Aug 12.Synthesis and pharmacological evaluation of sulfamide-based analogues of anandamide.
Ref 530389Eur J Med Chem. 2009 Dec;44(12):4889-95. Epub 2009 Aug 12.Synthesis and pharmacological evaluation of sulfamide-based analogues of anandamide.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.